Great question about China. The primary reason that we've seen for the china slowdown a lot of the product that we sell into china is related to respiratory pat testing for respiratory infections and um in asia there's uh you know, for folks that have traveled there, common areas of buildings are typically not heated. There's also a high population density and there is a fair bit of pollution as well. So between Between crowding, you know, pollution and unheated buildings, a lot of times people have a low level respiratory infection. And PCR tests are not really good, are not that quantifiable in the ways they're used there. So they prefer to do immunologic testing, looking for acute phase antibody reactions as really diagnostic as to whether you have an active infection with a clinical impact. And we've been supporting those tests. So there was a lot of what was called white lung or we would call it walking pneumonia in the 2023-2024 season in China.

Aug 14, 2025 / CEO / receipt, needs a key / Cameron Groom, CEO | earnings call 2025-08-14 | transcript dafed060-779b-4028-a7b9-4016b9e941b0 | chars 21160-22125 | segment 19